Using quality indicators to compare outcomes of permanent cardiac pacemaker implantation among publicly and privately funded patients
- 28 July 2015
- journal article
- research article
- Published by Wiley in Internal Medicine Journal
- Vol. 45 (8) , 813-820
Abstract
Background: Funding source/insurance status has been associated with disparity in the management and outcomes of cardiovascular disease, with poorer outcomes among disadvantaged groups.Aim: Using proposed quality indicators for permanent pacemaker (PPM) implantation and administrative data, this study aimed to determine whether quality indicator‐based outcomes of PPM implantation were comparable for publicly and privately funded patients within Australia's two‐tier health system.Methods: A population‐based cohort study of adults implanted with a PPM between 1995 and 2009 in Western Australia. The association of funding outcomes derived from linked administrative data was tested in multivariate logistic regression models.Results: There were 9748 PPMs implanted, 48% being among privately funded patients. The mean age was 75 years for both public and private patients. Private patients had better health status (fewer with cardiac conditions and lower non‐cardiac comorbidity scores), were less likely to be an emergency admission (33% vs 60%, P < 0.001) and more likely to have dual‐ or triple‐chamber pacing. Mean length of stay was significantly greater for private patients (4.3 (standard deviation 6.3) vs 5.1 (6.8) days <0.001), related to longer elective admissions. Crude mortality was lower for private patients in‐hospital (0.7 vs 1.3%), 30‐day post‐procedure (1.3 vs 2.1%) and at 1 year (7.3 vs 9.5%). Emergency admission, comorbidity and other demographic and clinical factors, not funding source, were significant predictors of these outcomes.Conclusions: There was no difference between publicly and privately funded patients in study outcomes, after adjustment for demographic and clinical factors. The exception was longer hospital stay for elective PPM among privately funded patients.Keywords
Funding Information
- National Heart Foundation of Australia (G 08A 3656)
- National Heart Foundation of Australia (G 11P 5661)
This publication has 19 references indexed in Scilit:
- 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA)EP Europace, 2013
- Impact of Community Wealth on Use of Cardiac-Resynchronization Therapy With Defibrillators for Heart Failure PatientsCirculation: Cardiovascular Quality and Outcomes, 2012
- Trends in Permanent Pacemaker Implantation in the United States From 1993 to 2009JACC, 2012
- Waiting for a pacemaker: is it dangerous?EP Europace, 2012
- Determinants of geographic variations in implantation of cardiac defibrillators in the European Society of Cardiology member countries--data from the European Heart Rhythm Association White BookEP Europace, 2011
- The impact of reimbursement on the usage of pacemakers, implantable cardioverter defibrillators and radiofrequency ablationJournal of Interventional Cardiac Electrophysiology, 2006
- Effects of race and health insurance on the rates of pacemaker implantation for complete heart block in the United StatesThe American Journal of Cardiology, 2004
- Differential effect of socioeconomic status on rates of invasive coronary procedures across the public and private sectors in Queensland, AustraliaJournal of Epidemiology and Community Health, 2002
- Coronary angiography and coronary artery revascularisation rates in public and private hospital patients after acute myocardial infarctionMedical Journal of Australia, 2000
- Permanent Pacemaker Selection and Subsequent Survival in Elderly Medicare Pacemaker RecipientsCirculation, 1995